masoprocol has been researched along with Colitis, Granulomatous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allison, AC; Baumann, R; Duclos, B; Dumont, S; Kenney, JS; Muller, CD; Poindron, P; Reimund, JM | 1 |
| Kane, MG; MacDermott, RP; Steele, LL; Stenson, WF | 1 |
2 other study(ies) available for masoprocol and Colitis, Granulomatous
| Article | Year |
|---|---|
Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn's disease and ulcerative colitis.
Topics: Adult; Antioxidants; Butylated Hydroxyanisole; Cell-Free System; Cells, Cultured; Colitis, Ulcerative; Crohn Disease; Cytokines; Dimethyl Sulfoxide; Humans; Intestinal Mucosa; Leukocytes, Mononuclear; Masoprocol; Middle Aged; Organ Culture Techniques | 1998 |
Inhibition of cytotoxicity by sulfasalazine. I. Sulfasalazine inhibits spontaneous cell-mediated cytotoxicity by peripheral blood and intestinal mononuclear cells from control and inflammatory bowel disease patients.
Topics: Catechols; Colitis, Ulcerative; Crohn Disease; Cytotoxicity, Immunologic; Humans; Hydrocortisone; Intestines; Leukocytes; Masoprocol; Sulfapyridine; Sulfasalazine | 1986 |